{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:32:41Z","timestamp":1757777561018,"version":"3.37.3"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Daiichi Sankyo India Pharma Private Limited"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1093\/jac\/dkz119","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T18:49:49Z","timestamp":1553712589000},"page":"1962-1970","source":"Crossref","is-referenced-by-count":7,"title":["Potential of the fluoroketolide RBx\u00a014255 against Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae in an experimental murine meningitis model"],"prefix":"10.1093","volume":"74","author":[{"given":"Tarani Kanta","family":"Barman","sequence":"first","affiliation":[{"name":"Department of Microbiology, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India"},{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6911-6907","authenticated-orcid":false,"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India"},{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tridib","family":"Chaira","sequence":"additional","affiliation":[{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"},{"name":"Department of Drug Metabolism and Pharmacokinetics, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India"},{"name":"Centre for Drug Design Discovery and Development (C4D), SRM University, Delhi-NCR, Sonepat, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramkumar","family":"Gangadharan","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India"},{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"},{"name":"Centre for Drug Design Discovery and Development (C4D), SRM University, Delhi-NCR, Sonepat, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Singhal","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India"},{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhvi","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India"},{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarun","family":"Mathur","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India"},{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pragya","family":"Bhateja","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India"},{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Pandya","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India"},{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkataramanan","family":"Ramadass","sequence":"additional","affiliation":[{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"},{"name":"Department of Medicinal Chemistry, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjan","family":"Chakrabarti","sequence":"additional","affiliation":[{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biswajit","family":"Das","sequence":"additional","affiliation":[{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"},{"name":"Department of Medicinal Chemistry, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilip J","family":"Upadhyay","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India"},{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V Samuel","family":"Raj","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India"},{"name":"New Drug Discovery Research, Ranbaxy Research Laboratories, R & D III, Gurgaon, India"},{"name":"Centre for Drug Design Discovery and Development (C4D), SRM University, Delhi-NCR, Sonepat, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"key":"2019062107404203300_dkz119-B1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.pcl.2005.02.011","article-title":"Bacterial meningitis in children","volume":"52","author":"Chavez-Bueno","year":"2005","journal-title":"Pediatr Clin North Am"},{"key":"2019062107404203300_dkz119-B2","first-page":"443","volume-title":"Textbook of Pediatric Infectious Diseases","author":"Feigin","year":"2003","edition":"5"},{"key":"2019062107404203300_dkz119-B3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMra052116","article-title":"Community-acquired bacterial meningitis in adults","volume":"354","author":"van de Beek","year":"2006","journal-title":"N Engl J Med"},{"key":"2019062107404203300_dkz119-B4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1473-3099(14)70805-9","article-title":"Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study","volume":"14","author":"Castelblanco","year":"2014","journal-title":"Lancet Infect Dis"},{"year":"2017","key":"2019062107404203300_dkz119-B5"},{"key":"2019062107404203300_dkz119-B6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/clinids\/24.Supplement_2.S213","article-title":"The challenge of penicillin resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s","volume":"24","author":"Bradley","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2019062107404203300_dkz119-B7","first-page":"662","article-title":"Cephalosporin treatment failure in penicillin and cephalosporin resistant Streptococcus pneumoniae meningitis","volume":"11","author":"Sloas","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"2019062107404203300_dkz119-B8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00006454-199111000-00018","article-title":"Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to \u03b2-lactam antibiotics","volume":"10","author":"Bradley","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"2019062107404203300_dkz119-B9","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","article-title":"Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States","volume":"343","author":"Whitney","year":"2000","journal-title":"N Engl J Med"},{"key":"2019062107404203300_dkz119-B10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9343(99)80271-X","article-title":"Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis","volume":"102","author":"Pacheco","year":"1997","journal-title":"Am J Med"},{"key":"2019062107404203300_dkz119-B11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/clinids\/18.2.188","article-title":"Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review","volume":"18","author":"John","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2019062107404203300_dkz119-B12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/clinids\/18.5.766","article-title":"Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae","volume":"18","author":"Catalan","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2019062107404203300_dkz119-B13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/AAC.43.2.329","article-title":"Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates, including those with mutations in the gyrA, parC and parE loci","volume":"43","author":"Jorgensen","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107404203300_dkz119-B14","doi-asserted-by":"crossref","first-page":"1116.","DOI":"10.1128\/AAC.44.4.1116-1116.2000","article-title":"An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones","volume":"44","author":"Shultz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107404203300_dkz119-B15","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3201\/eid1310.060820","article-title":"Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India","volume":"13","author":"Singhal","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"2019062107404203300_dkz119-B16","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1017\/S0950268808001398","article-title":"Outbreak of meningococcal disease in and around New Delhi, India, 2005\u20132006: a report from a tertiary care hospital","volume":"137","author":"Nair","year":"2009","journal-title":"Epidemiol Infect"},{"key":"2019062107404203300_dkz119-B17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijmm.2017.04.003","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae isolates in Germany from 2004-2005 to 2014-2015","volume":"307","author":"Schmitz","year":"2017","journal-title":"Int J Med Microbiol"},{"key":"2019062107404203300_dkz119-B18","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1016\/j.vaccine.2018.07.037","article-title":"Incidence and aetiology of bacterial meningitis among children aged 1-59 months in South Asia: systematic review and meta-analysis","volume":"36","author":"Ali","year":"2018","journal-title":"Vaccine"},{"key":"2019062107404203300_dkz119-B19","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1128\/AAC.00015-12","article-title":"In vitro and in vivo activities of the novel ketolide RBx\u00a014255 against Clostridium difficile","volume":"56","author":"Kumar","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107404203300_dkz119-B20","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1128\/AAC.01589-13","article-title":"A novel ketolide, RBx\u00a014255, with activity against multidrug-resistant Streptococcus pneumoniae","volume":"58","author":"Raj","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically\u2014Ninth Edition: Approved Standard M7-A09","year":"2012","key":"2019062107404203300_dkz119-B21"},{"key":"2019062107404203300_dkz119-B22","doi-asserted-by":"crossref","first-page":"7134","DOI":"10.1128\/AAC.00453-16","article-title":"In vitro and in vivo activities of a bi-aryl oxazolidinone, RBx\u00a011760, against Gram-positive bacteria","volume":"60","author":"Barman","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107404203300_dkz119-B23","doi-asserted-by":"crossref","first-page":"50.","DOI":"10.1186\/1471-2334-9-50","article-title":"Daptomycin in experimental murine pneumococcal meningitis","volume":"9","author":"Mook-Kanamori","year":"2009","journal-title":"BMC Infect Dis"},{"key":"2019062107404203300_dkz119-B24","doi-asserted-by":"crossref","first-page":"71.","DOI":"10.1186\/1471-2334-12-71","article-title":"Characterization of a pneumococcal meningitis mouse model","volume":"12","author":"Mook-Kanamori","year":"2012","journal-title":"BMC Infect Dis"},{"key":"2019062107404203300_dkz119-B25","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.38.6.1320","article-title":"Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis","volume":"38","author":"Paris","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107404203300_dkz119-B26","first-page":"449","article-title":"A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease","volume":"102","author":"Gerber","year":"2001","journal-title":"Acta Neuropathol (Berl)"},{"key":"2019062107404203300_dkz119-B27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1473-3099(02)00450-4","article-title":"Pathogenesis and pathophysiology of pneumococcal meningitis","volume":"2","author":"Koedel","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"2019062107404203300_dkz119-B28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0076-6879(94)35134-1","article-title":"Animal models for meningitis","volume":"235","author":"Tauber","year":"1994","journal-title":"Methods Enzymol"},{"key":"2019062107404203300_dkz119-B29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12028-010-9387-5","article-title":"Diffuse cerebral intravascular coagulation and cerebral infarction in pneumococcal meningitis","volume":"13","author":"Vergouwen","year":"2010","journal-title":"Neurocrit Care"},{"key":"2019062107404203300_dkz119-B30","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4103\/0971-5916.90997","article-title":"Non-invasive real-time monitoring of bacterial infection and therapeutic effect of anti-microbials in five mouse models","volume":"134","author":"Barman","year":"2011","journal-title":"Indian J Med Res"},{"key":"2019062107404203300_dkz119-B31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/jac\/dkm505","article-title":"Effects of EDP-420 on penicillin-resistant and quinolone- and penicillin-resistant pneumococci in the rabbit meningitis model","volume":"61","author":"Armin","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2019062107404203300_dkz119-B32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/jac\/dki034","article-title":"Penetration of telithromycin into the nasal mucosa and ethmoid bone of patients undergoing rhinosurgery for chronic sinusitis","volume":"55","author":"Kuehnel","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"2019062107404203300_dkz119-B33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/dkh068","article-title":"Tissue kinetics of telithromycin, the first ketolide antibacterial","volume":"53","author":"Muller-Serieys","year":"2004","journal-title":"J Antimicrobial Chemother"},{"key":"2019062107404203300_dkz119-B34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/dkf808","article-title":"Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin","volume":"50","author":"Felmingham","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"2019062107404203300_dkz119-B35","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1128\/AAC.00860-10","article-title":"Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis","volume":"54","author":"Llano-Sotelo","year":"2010","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/advance-article-pdf\/doi\/10.1093\/jac\/dkz119\/28553926\/dkz119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/7\/1962\/28851648\/dkz119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T13:17:07Z","timestamp":1663161427000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/7\/1962\/5485015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,2]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,5,2]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz119","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"type":"print","value":"0305-7453"},{"type":"electronic","value":"1460-2091"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,5,2]]}}}